Abemaxen® 150 mg (Abemaciclib) – A Trusted CDK4/6 Inhibitor for HR+ / HER2– Breast Cancer

Abemaxen® 150 mg is a prescription oral medication containing Abemaciclib, a targeted therapy used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) breast cancer. It belongs to a class of drugs called CDK4/6 inhibitors, which work by interrupting the growth cycle of cancer cells. Manufactured by Everest Pharma Ltd. in Bangladesh, Abemaxen offers a reliable, cost-effective alternative to expensive branded versions — making life-saving treatment more accessible.

When you or a loved one is facing hormone receptor-positive (HR+), HER2-negative breast cancer, every treatment decision matters. Abemaxen® 150 mg offers a clinically proven, affordable oral therapy that targets cancer growth at its source — without the need for IV infusions or hospital stays.

Manufactured by Everest Pharma Ltd. in Bangladesh, Abemaxen contains Abemaciclib, the same active ingredient found in the branded drug Verzenio® (Eli Lilly). It belongs to a class of medications called CDK4/6 inhibitors, which have transformed the treatment landscape for advanced breast cancer.

Whether you’re exploring first-line treatment options or managing disease progression, Abemaxen provides a reliable, cost-effective alternative that doesn’t compromise on quality or efficacy.

What Is Abemaxen 150 mg?

Abemaxen 150 mg is a prescription oral tablet used to treat HR+ / HER2– breast cancer in adults. Each film-coated tablet contains 150 mg of Abemaciclib — a targeted therapy that works by blocking two enzymes (CDK4 and CDK6) that cancer cells need to divide and multiply.

By interrupting this process, Abemaxen:

• Slows tumor growth

• Reduces the risk of cancer spreading

• Works synergistically with hormone therapies like aromatase inhibitors or fulvestrant

How Does Abemaxen Work?

Cancer cells are characterized by uncontrolled division. This happens when enzymes called cyclin-dependent kinases (CDK4 and CDK6) become overactive, pushing cells to multiply rapidly.

Abemaciclib — the active ingredient in Abemaxen — binds to these enzymes and blocks their activity. This stops cancer cells from progressing through their growth cycle, effectively putting the brakes on tumor expansion.

Because Abemaxen is selective, it targets cancer cells while minimizing damage to healthy cells — a key advantage over traditional chemotherapy.

Indications – Who Should Use Abemaxen?

Product Specifications

How to Take Abemaxen 150 mg

• Recommended dose: 150 mg twice daily (morning and evening) — total 300 mg/day

• With or without food: Take consistently the same way each day

• Swallow whole: Do not crush, chew, or split tablets

• Missed dose: Take as soon as you remember, unless it’s close to the next dose — never double up

• Grapefruit warning: Avoid grapefruit and grapefruit juice during treatment, as it can alter drug levels in your blood

Clinical Efficacy – What the Research Shows

Abemaciclib has been extensively studied in clinical trials, with results showing:

• Significant improvement in progression-free survival when combined with endocrine therapy

• Tumor shrinkage in a substantial portion of patients

• Well-tolerated side-effect profile compared to traditional chemotherapy

• Effective in both postmenopausal and premenopausal women when combined with ovarian suppression

These findings have made CDK4/6 inhibitors like Abemaxen a standard of care in HR+ / HER2– breast cancer management.

Common Side Effects of Abemaxen

While Abemaxen is generally well-tolerated, some patients may experience:

Your oncologist will monitor your blood counts regularly, as Abemaxen may cause low white blood cell counts, anemia, or low platelets in some patients.

Why Choose Abemaxen Over Branded Versions?

Who Should Not Take Abemaxen?

Abemaxen is not recommended for:

• Patients with a known hypersensitivity to Abemaciclib or any tablet ingredients

• Pregnant or breastfeeding women (effective contraception required)

• Patients with severe liver impairment (dose adjustment may be needed)

• Those with active infections or severely low blood cell counts

Always consult your oncologist before starting Abemaxen.

Drug Interactions to Be Aware Of

Abemaxen may interact with:

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) — may require dose reduction

• Strong CYP3A4 inducers (e.g., rifampin, phenytoin) — may reduce effectiveness

• Other medications that affect liver enzymes

Provide your doctor with a complete list of all medications you’re taking.

How to Order Abemaxen 150 mg Online

1. Consult your doctor – Abemaxen requires a valid prescription.

2. Contact us via WhatsApp or our website with your prescription.

3. Receive a quote – We’ll confirm availability and price.

4. Complete payment via Western Union, MoneyGram, Ria, or bank transfer.

5. Track your shipment – We’ll provide a DHL tracking number within 24 hours.

Frequently Asked Questions (FAQs)

Final Thoughts

Abemaxen® 150 mg represents a major step forward in breast cancer care. It’s effective, convenient, and — thanks to generic manufacturing — more affordable than ever before.

If you or a loved one are navigating the challenges of HR+ / HER2– breast cancer, Abemaxen offers a proven treatment option that fits into your life — not the other way around.

📌 Disclaimer

This product description is for informational and educational purposes only. Abemaxen® is a prescription medication and should only be taken under the supervision of a licensed oncologist. This website does not provide medical advice. Always consult your healthcare provider before starting or changing any treatment.